Annual progress of clinical research on targeted therapy for nonsmall cell lung cancer in 2022
Abstract With the rapid development of lung cancer molecular detection and precision therapy, targeted therapy has covered the entire process of diagnosis and treatment of nonsmall cell lung cancer patients. Overall mortality from lung cancer has decreased significantly over the past 20 years, espec...
Main Authors: | Yan Huang, Li Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Cancer Innovation |
Subjects: | |
Online Access: | https://doi.org/10.1002/cai2.56 |
Similar Items
-
Nephrotoxicity of targeted therapy used to treat lung cancer
by: Qiuling Li, et al.
Published: (2024-07-01) -
Recent Advances and Prospect of Advanced Non-small Cell Lung Cancer Targeted
Therapy: Focus on Small Molecular Tyrosine Kinase Inhibitors
by: Guowei ZHANG, et al.
Published: (2017-04-01) -
Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
by: Haoyue Hu, et al.
Published: (2023-08-01) -
Research Progress of Proteolysis Targeting Chimeria in NSCLC Therapy
by: Lin JIANG, et al.
Published: (2022-07-01) -
Advances of Neoadjuvant Targeted Therapy in ALK-positive Non-small Cell Lung Cancer
by: Weizhen SUN, et al.
Published: (2024-11-01)